Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM)
Ключови думи
Резюме
Описание
Background: The presence of Ala54Thr polymorphism of intestinal fatty acid-binding protein 2 gene (FABP2) might influence the intestinal absorption of dietary fatty acids (FAs) and has been associated with diabetic nephropathy.
Objective: We studied the postprandial serum FAs in type 2 diabetic patients homozygous for Thr54 (TT; n = 11) or for Ala54 (AA; n = 15) after a standard meal.Design: Patients received a sandwich (7.23 kcal/kg-total energy; 43.35% fat, 21.95% protein, and 34.70% carbohydrate) in the morning after 12-h fasting and FAs in chylomicrons (gas chromatograph), plasma glucose, and serum triacylglycerols were measured at 0, 2, 4, 6 and 8 h. Results: TT and AA patients did not differ regarding age (61.6±6.7 vs. 62.0±7.7years), diabetes duration (12.7±6.9 vs. 13.1±5.6years), male proportion (72.7 vs. 86.7%), blood pressure, type of diabetes treatment and previous macronutrients intake as well as serum A1C test (6.5±0.6 vs. 6.7±0.4%), LDL (3.0±1.0 vs. 3.2±0.6mmo/L), HDL (1.3±0.2 vs. 1.3±0.4mmol/L), triacylglycerols [1.6(1.0-3.4) vs. 1.6(0.6-3.7)mmol/L], saturated, monounsaturated, and polyunsaturated FAs, and trans-unsaturated FAs. The increase in serum glucose and triacylglycerols after the meal (ANOVA,P<0.001) was not different in both groups. The maximum increase of FAs occurred at 6-h postprandial, but only in TT patients: saturated FAs increased from 464.4(56.9-1602.5) to 1249.5(214.5-7149.8)mg/dL (P=0.041), monounsaturated FAs from 387.9(30.2-1523.8) to 925.1(344.6-5554.0)mgd/L (P=0.026), polyunsaturated FAs from 258.9(0-1048.5) to 713.1(143.7-7987.6)mg/dL (P=0.021), trans-unsaturated FAs from 18.5(1.9-70.6) to 66.5(5.0-451.7)mg/dL (P=0.023). Conclusion: The presence of the T allele of Ala54Thr polymorphism of FABP2 gene in type 2 diabetic patients increases absorption of dietary FAs, including the trans-unsaturated FAs, and this might turns these patients more susceptible to the effect of diet composition.
Дати
Последна проверка: | 01/31/2008 |
Първо изпратено: | 03/05/2008 |
Очаквано записване подадено: | 03/11/2008 |
Първо публикувано: | 03/12/2008 |
Изпратена последна актуализация: | 03/11/2008 |
Последна актуализация публикувана: | 03/12/2008 |
Действителна начална дата на проучването: | 05/31/2006 |
Приблизителна дата на първично завършване: | 09/30/2007 |
Очаквана дата на завършване на проучването: | 09/30/2007 |
Състояние или заболяване
Интервенция / лечение
Other: sandwich
Фаза
Групи за ръце
Arm | Интервенция / лечение |
---|---|
Other: TT patients homozygous for Thr54 (TT) | |
Other: AA patients homozygous for Ala54 (AA) |
Критерии за допустимост
Възрасти, отговарящи на условията за проучване | 40 Weeks Да се 40 Weeks |
Полове, допустими за проучване | All |
Приема здрави доброволци | Да |
Критерии | Inclusion Criteria: - Type 2 diabetes - homozygote to FABP2 polymorphism:TT or AA Exclusion Criteria: - age >75 years - glomerular filtration rate <30ml min-1 - with unstable angina or possible infarct or stroke in the last year |
Резултат
Първични изходни мерки
1. postprandial serum fatty acids [0, 2, 4,6, and 8 hours after meal]
Вторични изходни мерки
1. serum endothelin serum fibrinogen [0 and 8 hours after meal]